Footprint of APOBEC3 on the genome of human retroelements

Journal of Virology

Volumn 87, Issue 14, 2013, Pages 8195-8204

  Anwar, Firoz ^a   Davenport, Miles P ^a   Ebrahimi, Diako ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; HYDROLASE; PROTEIN APOBEC3; PROTEIN APOBEC3A; PROTEIN APOBEC3B; PROTEIN APOBEC3C; PROTEIN APOBEC3D; PROTEIN APOBEC3H; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; DNA FOOTPRINTING; DNA TRANSPOSITION; ENDOGENOUS RETROVIRUS; ENDOGENOUS VIRUS; GENE CLUSTER; GENE DELETION; GENE MUTATION; GENOME ANALYSIS; HUMAN; LONG INTERSPERSED REPEAT; MURINE LEUKEMIA VIRUS; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RETROPOSON; SEQUENCE ANALYSIS; SHORT INTERSPERSED REPEAT; SIMIAN SARCOMA VIRUS; VIRUS GENOME;

COMPUTATIONAL BIOLOGY; CYTOSINE DEAMINASE; EVOLUTION, MOLECULAR; GENOME, HUMAN; HUMANS; MARKOV CHAINS; MODELS, GENETIC; MUTATION; PROTEIN FOOTPRINTING; RETROELEMENTS;

EID: 84880284498     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00298-13     Document Type: Article

References (79)

1. Kazazian HH, Jr. 2004. Mobile elements: drivers of genome evolution. Science 303:1626-1632.
2. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange- Thomann N, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860-921.
3. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, Botcherby M, Bray N, Brent MR, Brown DG, Brown SD, Bult C, Burton J, Butler J, Campbell RD, Carninci P, Cawley S, Chiaromonte F, Chinwalla AT, Church DM, Clamp M, Clee C, Collins FS, Cook LL, Copley RR, Coulson A, Couronne O, Cuff J, Curwen V, Cutts T, Daly M, David R, Davies J, Delehaunty KD, Deri J, Dermitzakis ET, et al. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature 420:520-562.
4. Cullen BR. 2006. Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J. Virol. 80:1067-1076.
5. Belshaw R, Pereira V, Katzourakis A, Talbot G, Paces J, Burt A, Tristem M. 2004. Long-term reinfection of the human genome by endogenous retroviruses. Proc. Natl. Acad. Sci. U. S. A. 101:4894-4899.
6. Belshaw R, Dawson ALA, Woolven-Allen J, Redding J, Burt A, Tristem M. 2005. Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity. J Virol. 79:12507-12514.
7. Bannert N, Kurth R. 2004. Retroelements and the human genome: new perspectives on an old relation. Proc. Natl. Acad. Sci. U. S. A. 101:14572-14579.
8. Hughes JF, Coffin JM. 2004. Human endogenous retrovirus K solo-LTR formation and insertional polymorphisms: implications for human and viral evolution. Proc. Natl. Acad. Sci. U. S. A. 101:1668-1672.
9. Kijak GH, Janini LM, Tovanabutra S, Sanders-Buell E, Arroyo MA, Robb ML, Michael NL, Birx DL, McCutchan FE. 2008. Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells. Virology 376:101-111.
10. Khatua AK, Taylor HE, Hildreth JE, Popik W. 2010. Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F. Virology 400:68-75.
11. Beck CR, Collier P, Macfarlane C, Malig M, Kidd JM, Eichler EE, Badge RM, Moran JV. 2010. LINE-1 retrotransposition activity in human genomes. Cell 141:1159-1170.
12. Deininger PL, Batzer MA. 1999. Alu repeats and human disease. Mol. Genet. Metab. 67:183-193.
13. Dewannieux M, Esnault C, Heidmann T. 2003. LINE-mediated retrotransposition of marked Alu sequences. Nat. Genet. 35:41-48.
14. Rowold DJ, Herrera RJ. 2000. Alu elements and the human genome. Genetica 108:57-72.
15. Deininger PL, Batzer MA. 2002. Mammalian retroelements. Genome Res. 12:1455-1465.
16. Deininger PL, Moran JV, Batzer MA, Kazazian HH. 2003. Mobile elements and mammalian genome evolution. Curr. Opin. Genet. Dev. 13:651-658.
17. Mi S, Lee X, Li X, Veldman GM, Finnerty H, Racie L, LaVallie E, Tang XY, Edouard P, Howes S, Keith JC, McCoy JM. 2000. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403:785-789.
18. Rote NS, Chakrabarti S, Stetzer BP. 2004. The role of human endogenous retroviruses in trophoblast differentiation and placental development. Placenta 25:673-683.
19. Sekita Y, Wagatsuma H, Nakamura K, Ono R, Kagami M, Wakisaka N, Hino T, Suzuki-Migishima R, Kohda T, Ogura A, Ogata T, Yokoyama M, Kaneko-Ishino T, Ishino F. 2008. Role of retrotransposon-derived imprinted gene, Rtl1, in the feto-maternal interface of mouse placenta. Nat. Genet. 40:243-248.
20. Kazazian HH. 1999. An estimated frequency of endogenous insertional mutations in humans. Nat. Genet. 22:130.
21. Symer DE, Connelly C, Szak ST, Caputo EM, Cost GJ, Parmigiani G, Boeke JD. 2002. Human l1 retrotransposition is associated with genetic instability in vivo. Cell 110:327-338.
22. Arjan-Odedra S, Swanson CM, Sherer NM, Wolinsky SM, Malim MH. 2012. Endogenous MOV10 inhibits the retrotransposition of endogenous retroelements but not the replication of exogenous retroviruses. Retrovirology 9:53.
23. Barlow DP. 1993. Methylation and imprinting: from host defense to gene regulation? Science 260:309-310.
24. Chiu YL, Greene WC. 2008. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26:317-353.
25. Goodier JL, Cheung LE, Kazazian HH. 2012. MOV10 RNA helicase is a potent inhibitor of retrotransposition in cells. PLoS Genet. 8:e1002941. doi:10.1371/journal.pgen.1002941.
26. Harris RS, Liddament MT. 2004. Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol. 4:868-877.
27. Holmes RK, Malim MH, Bishop KN. 2007. APOBEC-mediated viral restriction: not simply editing? Trends Biochem. Sci. 32:118-128.
28. Kazazian HH. 2011. Host factors involved in L1 retrotransposition, p 203-205. In Mobile DNA: finding treasure in junk. FT Press, Upper Saddle River, NJ.
29. Yoder JA, Walsh CP, Bestor TH. 1997. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13:335-340.
30. Löwer R, Löwer J, Kurth R. 1996. The viruses in all of us-characteristics and biological significance of human endogenous retrovirus sequences. Proc. Natl. Acad. Sci. U. S. A. 93:5177-5184.
31. Maksakova IA, Romanish MT, Gagnier L, Dunn CA, van de Lagemaat LN, Mager DL. 2006. Retroviral elements and their hosts: insertional mutagenesis in the mouse germ line. PLoS Genet. 2:e2. doi:10.1371/journal.pgen.0020002.
32. Turelli P, Trono D. 2005. Editing at the crossroad of innate and adaptive immunity. Science 307:1061-1065.
33. LaRue RS, Jónsson SR, Silverstein KA, Lajoie M, Bertrand D, El-Mabrouk N, Hötzel I, Andrésdóttir V, Smith TP, Harris RS. 2008. The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. BMC Mol. Biol. 9:104.
34. Jern P, Stoye JP, Coffin JM. 2007. Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. PLoS Genet. 3:2014-2022. doi:10.1371/journal.pgen.0030183.
35. Sawyer SL, Emerman M, Malik HS. 2004. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2:E275. doi:10.1371/journal.pbio.0020275.
36. Zhang J, Webb DM. 2004. Rapid evolution of primate antiviral enzyme APOBEC3G. Hum. Mol. Genet. 13:1785-1791.
37. Holmes RK, Koning FA, Bishop KN, Malim MH. 2007. APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G. J. Biol. Chem. 282:2587-2595.
38. Liddament MT, Brown WL, Schumacher AJ, Harris RS. 2004. APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr. Biol. 14:1385-1391.
39. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. 2003. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103.
40. Pathak VK, Temin HM. 1990. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc. Natl. Acad. Sci. U. S. A. 87:6024-6028.
41. Armitage AE, Katzourakis A, de Oliveira T, Welch JJ, Belshaw R, Bishop KN, Kramer B, McMichael AJ, Rambaut A, Iversen AK. 2008. Conserved footprints of APOBEC3G on hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERVK(HML2) sequences. J. Virol. 82:8743-8761.
42. Esnault C, Priet S, Ribet D, Heidmann O, Heidmann T. 2008. Restric-tion by APOBEC3 proteins of endogenous retroviruses with an extracellular life cycle: ex vivo effects and in vivo "traces" on the murine IAPE and human HERV-K elements. Retrovirology 5:75.
43. Lee YN, Malim MH, Bieniasz PD. 2008. Hypermutation of an ancient human retrovirus by APOBEC3G. J. Virol. 82:8762-8770.
44. Ebrahimi D, Anwar F, Davenport MP. 2011. APOBEC3 has not left an evolutionary footprint on the HIV-1 genome. J. Virol. 85:9139-9146.
45. Ebrahimi D, Anwar F, Davenport MP. 2012. APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome. Retrovirology 9:113.
46. Hultquist JF, Lengyel JA, Refsland EW, LaRue RS, Lackey L, Brown WL, Harris RS. 2011. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J. Virol. 85:11220-11234.
47. Rice P, Longden I, Bleasby A. 2000. EMBOSS: the European molecular biology open software suite. Trends Genet. 16:276-277.
48. Dridi S. 2012. Alu mobile elements: from junk DNA to genomic gems. Scientifica 2012:1-11.
49. Renwick PJ, Birley AJ, Hultén MA. 1997. Study of Alu sequences at the hypoxanthine phosphoribosyltransferase (HPRT) encoding region of man. Gene 184:155-162.
50. Philips GJ, Arnold J, Ivarie R. 1987. Mono-through hexanucleotide composition of the Escherichia coli genome-a Markov chain analysis. Nucleic Acids Res. 15:2611-2626.
51. Subramanian RP, Wildschutte JH, Russo C, Coffin JM. 2011. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology 8:90.
52. Yi J-M, Kim H-S. 2007. Expression and phylogenetic analyses of human endogenous retrovirus HC2 belonging to the HERV-T family in human tissues and cancer cells. J. Hum. Genet. 52:285-296.
53. Werner T, Brack-Werner R, Leib-Mösch C, Backhaus H, Erfle V, Hehlmann R. 1990. S71 is a phylogenetically distinct human endogenous retroviral element with structural and sequence homology to simian sarcoma virus SSV. Virology 174:225-238.
54. Langlois M-A, Kemmerich K, Rada C, Neuberger MS. 2009. The AKV murine leukemia virus is restricted and hypermutated bymouseAPOBEC3.J. Virol. 83:11550-11559.
55. Perez-Caballero D, Soll SJ, Bieniasz PD. 2008. Evidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5alpha proteins. PLoS Pathog. 4:e1000181. doi:10.1371/journal.ppat.1000181.
56. Kim DDY, Kim TTY, Walsh T, Kobayashi Y, Matise TC, Buyske S, Gabriel A. 2004. Widespread RNA editing of embedded Alu elements in the human transcriptome. Genome Res. 14:1719-1725.
57. Levanon EY, Eisenberg E, Yelin R, Nemzer S, Hallegger M, Shemesh R, Fligelman ZY, Shoshan A, Pollock SR, Sztybel D, Olshansky M, Rechavi G, Jantsch MF. 2004. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat. Biotechnol. 22:1001-1005.
58. Paz-Yaacov N, Levanon EY, Nevo E, Kinar Y, Harmelin A, Jacob-Hirsch J, Amariglio N, Eisenberg E, Rechavi G. 2010. Adenosine-toinosine RNA editing shapes transcriptome diversity in primates. Proc. Natl. Acad. Sci. U. S. A. 107:12174-12179.
59. Callinan A, Batzer MA. 2006. Retrotransposable elements and human disease. Genome 1:104-115.
60. Chen J-M, Férec C, Cooper DN. 2006. LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease: mutation detection bias and multiple mechanisms of target gene disruption. J. Biomed. Biotech. 2006:1-10.
61. Esnault C, Heidmann O, Delebecque F, Dewannieux M, Ribet D, Hance AJ, Heidmann T, Schwartz O. 2005. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature 433:430-433.
62. Schumacher AJ, Nissley DV, Harris RS. 2005. APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast. Proc. Natl. Acad. Sci. U. S. A. 102:9854-9859.
63. Esnault C, Millet J, Schwartz O, Heidmann T. 2006. Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses. Nucleic Acids Res. 34:1522-1531.
64. Stopak K, de Noronha C, Yonemoto W, Greene WC. 2003. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12:591-601.
65. Zheng YH, Irwin D, Kurosu T, Tokunaga K, Sata T, Peterlin BM. 2004. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol. 78:6073-6076.
66. Oberste MS, Gonda MA. 1992. Conservation of amino-acid sequence motifs in lentivirus Vif proteins. Virus Genes 6:95-102.
67. Bogerd HP, Wiegand HL, Hulme AE, Garcia-Perez JL, O'Shea KS, Moran JV, Cullen BR. 2006. Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc. Natl. Acad. Sci. U. S. A. 103: 8780-8785.
68. Turelli P, Vianin S, Trono D. 2004. The innate antiretroviral factor APOBEC3G does not affect human LINE-1 retrotransposition in a cell culture assay. J. Biol. Chem. 279:43371-43373.
69. Cost GJ, Feng Q, Jacquier A, Boeke JD. 2002. Human L1 element target-primed reverse transcription in vitro. EMBO J. 21:5899-5910.
70. Ikeda T, Abd El Galil KH, Tokunaga K, Maeda K, Sata T, Sakaguchi N, Heidmann T, Koito A. 2011. Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons. Nucleic Acids Res. 39:5538-5554.
71. Stenglein MD, Harris RS. 2006. APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J. Biol. Chem. 281:16837-16841.
72. Chiu YL, Witkowska HE, Hall SC, Santiago M, Soros VB, Esnault C, Heidmann T, Greene WC. 2006. High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc. Natl. Acad. Sci. U. S. A. 103:15588-15593.
73. Hulme AE, Bogerd HP, Cullen BR, Moran JV. 2007. Selective inhibition of Alu retrotransposition by APOBEC3G. Gene 390:199-205.
74. Boeke JD, Stoye JP. 1997. Retrotransposons, endogenous retroviruses, and the evolution of retroelements. In Coffin JM, Hughes SH, Varmus HE (ed), Retroviruses. CSHL Press, New York, NY.
75. Temin HM. 1992. Origin and general nature of retroviruses, p 1-18. In Levy JA (ed), The Retroviridae. Plenum Press, New York, NY.
76. Dewannieux M, Harper F, Richaud A, Letzelter C, Ribet D, Pierron G, Heidmann T. 2006. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res. 16:1548-1556.
77. Chen H, Lilley CE, Yu Q, Lee DV, Chou J, Narvaiza I, Landau NR, Weitzman MD. 2006. APOBEC3A is a potent inhibitor of adenoassociated virus and retrotransposons. Curr. Biol. 16:480-485.
78. Lee YN, Bieniasz PD. 2007. Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog. 3:e10. doi:10.1371/journal.ppat.0030010.
79. Carmi S, Church GM, Levanon EY. 2011. Large-scale DNA editing of retrotransposons accelerates mammalian genome evolution. Nat. Commun. 2:519.